Clinical trial
Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer
NCT00126165 · Alberta Health services, Other · Completed
Key facts
| NCT number | NCT00126165 |
|---|---|
| Title | Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer |
| Official title | A Phase I/II Study of Escalated-dose Short-course Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer |
| Lead sponsor | Alberta Health services, Other |
| Collaborators | Calgary Health Region |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Procedure |
| Interventions | radiotherapy |
| Enrollment | 72 |
| Start date | Sep 1, 2004 |
| Completion | Aug 1, 2011 |
| First posted | Aug 3, 2005 |
| Last update posted | Jan 19, 2012 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: